Multiclass hepatitis C virus resistance to direct acting antivirals in real life interferon-free regimens failures advocates for tailored second-line therapiesVelia Chiara Di Maio, M. Paoloni, I. Lenci et al.|Journal of Hepatology|2017Cited by 2